Ocumetics Technology Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTCFF research report →
Price Chart
About the company
Specializing in research and product development, Ocumetics Technology Corp. engineers and manufactures a range of optical lenses. A flagship offering is the Bionic Lens, an innovative, expandable intraocular lens designed to be precisely placed within the eye's natural lens capsule, thereby removing the necessity for traditional corrective eyewear.
- CEO
- Dean E. Burns
- IPO
- 2021
- Employees
- 3
- HQ
- Calgary, AB, CA
Get TickerSpark's AI analysis on OTCFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $23.53M
- P/E
- -6.28
- PEG
- 0.09
- P/S
- 0.00
- P/B
- -10.45
- EV/EBITDA
- -6.87
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 196.46%
- ROIC
- -933.15%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-108,774+19.0%
- Op Income
- $-5,364,296
- Net Income
- $-5,373,327-77.8%
- EPS
- $-0.04-58.7%
- OCF Growth
- -38.5%
- FCF Growth
- -38.8%
- 52W High
- $1.13
- 52W Low
- $0.26
- 50D MA
- $0.35
- 200D MA
- $0.40
- Beta
- 0.34
- RSI (14)
- 68
- Avg Volume
- 5.96K
No earnings-call transcripts are available for OTCFF yet.
- Free Float
- 62.2%
- Shares Outstanding
- 58.91M
- Float Shares
- 36.67M
Our OTCFF coverage
Recent articles, reports, and earnings notes.
No research on OTCFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OTCFF report →Ocumetics Announces Completion of Second Tranche of Unit Private Placement
thenewswire.com · Jul 31
Ocumetics Announces Upsizing of Unit Private Placement
thenewswire.com · Jul 30
Ocumetics Announces Completion of First Tranche of Unit Private Placement
thenewswire.com · Jul 29
Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study
thenewswire.com · Jul 9
Ocumetics Announces Offering of Units
thenewswire.com · Jul 7
Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones
thenewswire.com · Jun 2
Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens
thenewswire.com · May 12
Ocumetics Announces Offering of Units
thenewswire.com · Apr 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.